导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -13.61% | 885/1050 |
| 近一周 | -2.79% | 730/1104 |
| 近一月 | -4.43% | 549/1102 |
| 近一季 | -17.05% | 901/1092 |
| 近半年 | -16.04% | 917/1070 |
| 近一年 | -12.91% | 776/1018 |
| 近两年 | 12.57% | 827/926 |
| 近三年 | -4.10% | 708/834 |
| 成立以来 | -42.39% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-5.61% 850/1070 |
20.08% 388/1101 |
- - |
- - |
| 2025 | 15.37% 749/1065 |
-0.82% 847/1014 |
0.23% 664/1038 |
17.58% 679/1050 |
-1.29% 516/1065 |
| 2024 | -1.04% 611/1011 |
-1.51% 401/960 |
-3.95% 569/983 |
13.71% 326/991 |
-8.00% 825/1011 |
| 2023 | -23.67% 755/952 |
-3.19% 753/880 |
-0.64% 221/895 |
-18.20% 838/915 |
-2.99% 330/952 |
| 2022 | -35.88% 712/867 |
-20.92% 570/773 |
3.58% 604/806 |
-15.36% 587/845 |
-7.53% 725/867 |
| 2021 | -1.62% 375/740 |
-5.85% 379/580 |
8.28% 404/659 |
-4.16% 318/704 |
0.69% 410/740 |
| 2020 | - - |
- - |
- - |
- - |
- - |
| 2019 | - - |
- - |
- - |
- - |
- - |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 广发研究精选股票C VS. 东吴新产业精选股票A(580008) |